drugset / Trial / NCT07195825
A Clinical Study to Evaluate the Safety, and Tolerability of BBM-P002 in the Treatment of Parkinson's Disease
NaSingle-groupOpen-labelTreatment
Summary
The purpose of the study is to evaluate the safety and tolerability of BBM-P002 for stereotactic injection to treat participants with idiopathic Parkinson's Disease (PD) during the dose-limiting toxicity (DLT) observation period.
Timeline
- Start
- 2025-12-27
- Primary completion
- 2027-12-30
- Completion
- 2031-12-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BBM-P002 | Gene therapy (AAV / viral vector) | — | Other |